mAbxience anuncia la aprobación por la Comisión Europea de sus biosimilares de denosumab

mAbxience Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

View original content:https://www.prnewswire.com/news-releases/mabxience-anuncia-la-aprobacion-por-la-comision-europea-de-sus-biosimilares-de-denosumab-302496771.html